
STENTiT Treats First Patient with Regenerative Stent in CLTI Study
STENTiT has successfully implanted its Resorbable Fibrillated Scaffold in the first patient enrolled in its VITAL-IT 1 clinical study for chronic limb-threatening ischemia (CLTI) below



